Kamada Ltd
NASDAQ:KMDA

Watchlist Manager
Kamada Ltd Logo
Kamada Ltd
NASDAQ:KMDA
Watchlist
Price: 5.9 USD 0.85%
Market Cap: 339.2m USD
Have any thoughts about
Kamada Ltd?
Write Note
KMDA
/
Balance Sheet
/
Cash Equivalents

Kamada Ltd
Cash Equivalents

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
|

Kamada Ltd
Cash Equivalents Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Cash Equivalents CAGR 3Y CAGR 5Y CAGR 10Y
Kamada Ltd
NASDAQ:KMDA
Cash Equivalents
$72m
CAGR 3-Years
-10%
CAGR 5-Years
21%
CAGR 10-Years
15%
Collplant Biotechnologies Ltd
NASDAQ:CLGN
Cash Equivalents
$26.7m
CAGR 3-Years
100%
CAGR 5-Years
38%
CAGR 10-Years
N/A
Urogen Pharma Ltd
NASDAQ:URGN
Cash Equivalents
$124.9m
CAGR 3-Years
31%
CAGR 5-Years
14%
CAGR 10-Years
N/A
Entera Bio Ltd
NASDAQ:ENTX
Cash Equivalents
$6.9m
CAGR 3-Years
-37%
CAGR 5-Years
3%
CAGR 10-Years
N/A
B
Bonus Biogroup Ltd
TASE:BONS
Cash Equivalents
₪14.1m
CAGR 3-Years
-44%
CAGR 5-Years
59%
CAGR 10-Years
40%
Pluri Inc
NASDAQ:PLUR
Cash Equivalents
$3.2m
CAGR 3-Years
-40%
CAGR 5-Years
-3%
CAGR 10-Years
-6%
No Stocks Found

Kamada Ltd
Glance View

Market Cap
339.1m USD
Industry
Biotechnology

Kamada Ltd. engages in the development and production of pharmaceutical products. The firm uses its proprietary platform technology and know-how for the extraction and purification of proteins from human plasma to produce Alpha-1 Antitrypsin (AAT) in a highly-purified, liquid form, as well as other plasma-derived Immune globulins.

KMDA Intrinsic Value
5.83 USD
Overvaluation 1%
Intrinsic Value
Price
What is Intrinsic Value?

See Also

What is Kamada Ltd's Cash Equivalents?
Cash Equivalents
72m USD

Based on the financial report for Sep 30, 2024, Kamada Ltd's Cash Equivalents amounts to 72m USD.

What is Kamada Ltd's Cash Equivalents growth rate?
Cash Equivalents CAGR 10Y
15%

Over the last year, the Cash Equivalents growth was 37%. The average annual Cash Equivalents growth rates for Kamada Ltd have been -10% over the past three years , 21% over the past five years , and 15% over the past ten years .

Back to Top
ALPHA SPREAD
Follow us
Join more than 210,400+ value investors using Alpha Spread
Create a free account
or see our plans & pricing

Company

About Us Careers Pricing Affiliate Program Terms of Service Privacy Policy

Help

What is Intrinsic Value? Help Center Contact Us

Tools

Stock Screener Intrinsic Value Calculator DCF Value Calculator Discount Rate Calculator

Stocks

Most Undervalued Stocks Wide Economic Moat Stocks High Profitability Stocks High Solvency Stocks Most Popular Stocks

© 2024 Alpha Spread Limited. All Rights Reserved.

www.alphaspread.com is not operated by a broker, a dealer, or a registered investment adviser. Under no circumstances does any information posted on www.alphaspread.com represent a recommendation to buy or sell a security. The information on this site, and in its related newsletters, is not intended to be, nor does it constitute, investment advice or recommendations. The information on this site is in no way guaranteed for completeness, accuracy or in any other way. In no event shall Alpha Spread Limited be liable to any member, guest or third party for any damages of any kind arising out of the use of any content or other material published or available on www.alphaspread.com, or relating to the use of, or inability to use, www.alphaspread.com or any content, including, without limitation, any investment losses, lost profits, lost opportunity, special, incidental, indirect, consequential or punitive damages. Past performance is a poor indicator of future performance.